社区获得性MRSA下呼吸道感染临床特征分析  

Clinical analysis of community-acquired lower respiratory infection due to methicillin-resistant Staphylococcus aureus

作　　者：韩李周[1] 郑红[1] 陈晓霞[1] 靳双周[1] 

机构地区：[1]河南省焦作市人民医院呼吸内科,焦作454002

出　　处：《临床医学》2014年第9期10-12,共3页Clinical Medicine

摘　　要：目的探讨社区获得性耐甲氧西林金黄色葡萄球菌(MRSA)下呼吸道感染的临床特征、诊断与治疗。方法回顾性分析焦作市人民医院呼吸内科收治的6例社区获得性MRSA下呼吸道感染患者的临床资料。结果 6例患者均好转出院,随访3个月,1例出现肺部结构及功能受损,余无复发及不适。结论社区获得性MRSA下呼吸道感染不具备医院获得性MRSA感染的高危因素,见于免疫功能正常的青年及老年人,也可见于合并糖尿病等患者,CT具有坏死性肺炎的特征,可形成肺脓肿甚至脓气胸,糖肽类抗生素或利奈唑胺治疗有效,联合克林霉素或许能使患者受益。Objective To investigate the clinical characteristics,diagnosis and treatment of community-acquired methicillin-resistant Staphylococcus aureus（ CA-MRSA）lower respiratory infection. Methods The clinical data of 6 patients with CA-MR-SA lower respiratory infection were retrospectively analyzed. Results All patients were cured,but the lung structure and func-tion of 1 patient was damaged. Conclusion The people with normal immune function and patients with diabetes can suffer from CA-MRSA lower respiratory infection,which including necrotising pneumonia,lung abscess,pyopneumothorax. Glycopeptide an-tibiotics and linezolid are effective and the patients may benefit from clindamycin therapy.

关 键 词：社区获得性耐甲氧西林金黄色葡萄球菌 下呼吸道感染 糖肽类抗生素 利奈唑胺 克林霉素 

分 类 号：R56[医药卫生—呼吸系统]